ESTA Stock News & Catalysts – Establishment Labs

Establishment Labs® to Announce Third Quarter 2026 Financial Results on October 29

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its

Oct 19, 2026, 8:00 AM ·Business Wire

Establishment Labs® Receives FDA Approval for Additional Sizes of Motiva Implants®

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced that the U.S. Food

Oct 5, 2026, 8:00 AM ·Business Wire

Establishment Labs® Highlights New Breast Tissue Preservation Data and Announces Minimally Invasive Product Extensions at the 11th World Symposium on Ergonomic Implants

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced the presentation of

Sep 21, 2026, 8:00 AM ·Business Wire

A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

NEW YORK, Sept. 1, 2026 /PRNewswire/ -- Equity Insider News Commentary - The global medical aesthetics market has quietly become one of the most durable growth stories in healthcare. Multiple market-research firms size

Sep 1, 2026, 11:37 AM ·PRNewswire

The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For

RENO, Nev., Aug. 12, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary - The weight-loss drug boom has been one of the defining healthcare stories of the decade, and its success has created a second-order

Aug 12, 2026, 9:15 AM ·Globe Newswire

Establishment Labs® Reports Second Quarter 2026 Financial Results

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced financial

Aug 6, 2026, 8:00 AM ·Business Wire

Establishment Labs® to Announce Second Quarter 2026 Financial Results on August 6

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its

Jul 23, 2026, 8:00 AM ·Business Wire

A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity

Issued on behalf of Conexeu Sciences Inc. Conexeu Sciences Inc. (NASDAQ:CNXU) opened a new research and development facility at adMare BioInnovations’ M4 Innovation Centre, expanding the home of its CXU™ regenerative

Jul 1, 2026, 9:05 AM ·Globe Newswire

Establishment Labs® Appoints Taylor Harris to Board of Directors

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, announced today the

Jun 29, 2026, 8:00 AM ·Business Wire

The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It

Issued on behalf of Conexeu Sciences Inc. With Galderma now presenting clinical data on treating medication-driven facial volume loss, the GLP-1 aesthetics category has gone mainstream — and Conexeu Sciences Inc.

Jun 25, 2026, 9:04 AM ·Globe Newswire

Establishment Labs® Added to Membership of U.S. Small-Cap Russell 2000® Index

Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, will be added as a member of

Jun 25, 2026, 8:00 AM ·Business Wire

Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower

Issued on behalf of Conexeu Sciences Inc.A clutch of new directors with Fortune 500 finance, M&A, and aesthetics pedigrees signals that the newly public tissue-regeneration company is building for commercialization —

Jun 16, 2026, 8:15 AM ·PRNewswire

After Fifty Years of Implants, a Newly Public Biotech Is Trying to Rebuild the Breast Instead

Conexeu Sciences just 3D-bioprinted a new tissue matrix to one of the most respected regenerative medicine institutes in the world. For investors watching how breast reconstruction — and the wider field of tissue

May 27, 2026, 9:00 AM ·Globe Newswire

The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself

Issued on behalf of Conexeu Sciences Inc.A biotech debut out of Reno is betting that the next wave of medicine won't replace tissue — it'll grow it back.NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News

May 22, 2026, 11:30 AM ·Globe Newswire

Establishment Labs Holdings Inc. ESTA · News